Delivery Order SPE2DB22D3016-SPE2DB25FBFV1
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,680.12 to AmerisourceBergen Drug Corp for Mucinex D ER 600-60 mg tablets (18-count packaging) on July 31, 2025, with an ultimate completion date of August 1, 2025. This non-set-aside, competitively awarded contract utilized firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger federal contract portfolio. The product will be delivered to the company's headquarters location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,410.00 to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Mucinex D ER 600-60 mg tablets (18-count packages). This is a firm fixed-price delivery order with an ultimate completion date of August 19, 2025, and represents a non-competitive set-aside. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency awarded a $3,013.61 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Mucinex D ER 600-60 mg tablets (18-count units) on July 24, 2025, with completion targeted for July 25, 2025. This non-set-aside delivery order represents a routine pharmaceutical supply transaction supporting federal medical procurement needs. The award was issued to AmerisourceBergen's Corporate Office division, with performance to occur at the company's headquarters in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Mucinex D ER 600-60 mg tablets (18-count packages) with a ceiling value of $1,509.56. This competitive, firm fixed-price delivery order was awarded on August 13, 2025, with an ultimate completion date of August 14, 2025. The pharmaceutical product will be performed and delivered from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $2,129.30 for Mucinex D ER 600-60 mg tablets (18-count) on August 21, 2025, with an ultimate completion date of August 22, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed price terms and represents a child delivery order under AmerisourceBergen's existing DLA Troop Support Medical Indefinite Delivery Contract (IDC SPE2DX), valued at $999,999,999.00 and extending...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,750.46 to AmerisourceBergen Drug Corp for the supply of Mucinex ER 1,200 mg tablets (14-count packages). This firm fixed price delivery order was competitively awarded without set-aside provisions and is scheduled for completion by August 13, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. This...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,389.38 on August 13, 2025, for the supply of Mucinex D ER 600-60 mg tablets (18-count package). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 14, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under the...
- The Defense Logistics Agency has awarded AmerisourceBergen Drug Corp a delivery order valued at $1,295.32 for Mucinex D ER 600-60 mg tablets (18-count). This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by August 5, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Mucinex D ER 1,200-120 mg tablets (24-count packages) valued at $3,066.65. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract under open competition. The order is scheduled for ultimate completion on August 21, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,877.76 to AmerisourceBergen Drug Corp for the supply of Mucinex D ER 600-60 mg tablets (18-count units). The contract was awarded on August 15, 2025, with an ultimate completion date of August 18, 2025, and is structured as a firm fixed price delivery order with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FBFV1Delivery Order
The Defense Logistics Agency awarded a $1,553.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Mucinex D ER 1,200-120 mg tablets (24-count package) on August 21, 2025, with completion scheduled for August 22, 2025. This non-set-aside contract represents a routine pharmaceutical supply delivery executed through AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract was fulfilled at AmerisourceBergen's corporate headquarters location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's comprehensive $999.999 billion IDC (SPE2DX) with DLA Troop Support Medical, which extends through December 2026 and serves as a global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, supplies an extensive portfolio of brand-name and generic medications, vaccines, and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The pharmaceutical distributor's consistent performance across multiple therapeutic domains and competitive contract awards demonstrates its established capability to meet federal medical supply requirements at scale.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 8/21/25 |